Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical and Quantitative Research

Europe Next to Break Out?; Bullish Outlook Intact; Remain Overweight Korea, Greece, and the U.S.

Upgrading China to Overweight; Europe Breaking Out

Sticking With China; Bullish Outlook Intact. Buys in Consumer Discretionary, Materials, and Tech

Upgrading Korea to Overweight; MSCI ACWI and Emerging Market Breakouts

Downgrading Germany and Ireland; Global Technology Still Leading; Crucial Base Supports Holding

China and Japan Breaking Out -- Buy; Bullish Outlook Intact; U.S. Dollar (DXY) Remains Weak

Israel TA-125 Remains Bullish; Buys in Norway; All MSCI Global Indexes Above Base Supports

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical Analysis

<ul>
<li>We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass), with Int’l Compass reports all echoing this sentiment.</li>
<li>We will maintain our bullish intermediate-term view as long as market dynamics remain healthy and the SPX and ACWI-US are above 6028-6059 (up from 5700-5785) and $119-$121.</li>
<li>$128, $125-$126, and $123-$123.50 are short-term supports to watch on ACWI-US; we will maintain our near-term bullish outlook as long as $123 support holds.</li>
</ul>


We remain near-term bullish since our 4/22/25 Compass, and our intermediate-term outlook remains bullish as well (as of our 5/14/25 Compass), with Int’l Compass reports all echoing this sentiment.
We will maintain our bullish intermediate-term view as long as market dynamics remain healthy and the SPX and ACWI-US are above 6028-6059 (up from 5700-5785) and $119-$121.
$128, $125-$126, and $123-$123.50 are short-term supports to watch on ACWI-US; we will maintain our near-term bullish outlook as long as $123 support holds.


Japan Metropolitan Fund Investment Corporation (8953 JP)

Japan Metropolitan Fund Investment Corporation

Wus Printed Circuit (Kunshan) Co,Ltd. (002463 CH)

Yangzhou Yangjie Electronic Technology (300373 CH)

Zhejiang Huahai Pharmaceutical Co, Ltd. (600521 CH)

Shanghai Stock Exchange Composite Index (SHCOMP INDEX)

HDFC Asset Management Co Ltd (HDFCAMC IN)

Shandong Buchang Pharmaceutica (603858 CH)

G-bits Network Technology Xiam (603444 CH)

Autel Intelligent Technology C (688208 CH)

Tencent Music Entertainment Group (1698 HK)

Shanghai Allist Pharmaceuticals (688578 CH)

Continue Adding Exposure to China; Short-Term Supports to for This ACWI-US Pullback

BeiGene

Continue Adding Exposure to China; Short-Term Supports to for This ACWI-US Pullback